21/09/2026
Symposium 3 Highlights | UAERDSC 2026 🧬
Day 2 of the 4th International UAE Rare Disease Society Congress featured the BioMarin – Taiba Access Rare Symposium, with Dr. Sareea Al Remeithi, UAE, Consultant Pediatric Endocrinology at Sheikh Khalifa Medical City, Abu Dhabi, presenting “Achondroplasia: From Pathophysiology to Targeted Therapy.”
Dr. Al Remeithi shared valuable clinical insights into achondroplasia, exploring its underlying pathophysiology and the evolving landscape of targeted therapeutic approaches.
Her presentation highlighted how advances in understanding the molecular mechanisms of achondroplasia are contributing to new approaches in management and reinforcing the importance of specialized, multidisciplinary care for individuals living with rare skeletal conditions.
Thank you, Dr. Sareea Al Remeithi, for sharing your expertise with our delegates, and to BioMarin and Taiba Access Rare for supporting this important scientific symposium at UAERDSC 2026.
United for Rare: Empowering Families, Advancing Care.